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Background: Darier disease (DD) is a rare autosomal dominant condition characterized by skin lesions. Addi-
tionally, a wide range of neuropsychiatric symptoms is frequently reported in DD patients. This genodermatosis
relies on mutations in the ATPase sarcoplasmic/endoplasmic reticulum Ca2þ transporting 2 (ATP2A2) gene,
which encodes an ATPase responsible for pumping Ca2þ from the cytosol to the lumen of the ER.
Objective: Herein we studied the molecular aspect of a two-generation Portuguese family with DD history with
clinical variability.
Methods: All exons and intron-exon borders of genomic ATP2A2, as well as coding ATP2A2, were sequenced.
Relative levels of SERCA2 mRNA and protein were quantiﬁed by qPCR and western blotting, respectively.
Results: The c.1287þ1G > T variant was identiﬁed in all affected individuals, whereas the unaffected individual
was shown to carry the wild-type ATP2A2 sequence in both alleles. This variant leads to the skipping of full exon
10, which consequently generates a frameshift originating a premature STOP codon in exon 11 (p.V395 ¼ fs*19).
Although the mutant mRNA seems to partially escape degradation, results suggest synthesis inhibition or im-
mediate degradation of the mutant protein. Neuropsychiatric and other occurrences affecting certain patients are
also reported.
Conclusion: This is the ﬁrst study of DD in Portugal, the variant identiﬁed, previously described in a single Jap-
anese patient, may be considered a pathogenic mutation, and haploinsufﬁciency the mechanism underlying DD
pathology in these patients. This study also highlights the co-occurrence of neuropsychiatric features in DD.1. Introduction
Darier Disease (DD, OMIM #124200) is a rare autosomal dominant
genodermatosis, with complete penetrance and variable expressivity. It is
caused by heterozygous mutation in the ATPase sarcoplasmic/endo-
plasmic reticulum Ca2þ transporting 2 (ATP2A2) gene, which encodes
the Sarco/Endoplasmic Reticulum Ca2þ ATPase 2 (SERCA2), responsible
for pumping Ca2þ from cytosol to the lumen of the ER. According to
Leiden Open Variation Database v3.0 (http://www.lovd.nl/3.0/home),
420 public variants have been reported in the ATP2A2 gene, of which
295 are unique.
ATP2A2 is transcribed into 21 exons and alternative splicing of the
pre-mRNA generates multiple isoforms [1, 2]. These isoforms vary in
their tissue expression pattern: SERCA2a has been found to be restrained
to cardiac slow-twitch muscle, skeletal and smooth muscle [3], whereas
SERCA2b is the ubiquitous isoform, expressed in non-muscle cells,.
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is an open access article under tincluding several areas of the brain [4], and highly expressed in the
epidermis [1, 5].
At a molecular level, ATP2A2mutations lead to depletion of ER Ca2þ
stores and ER stress, particularly in the skin [1]. Haploinsufﬁciency or
dominant-negative effect have been the mechanisms postulated for DD
pathology [6, 7, 8]. Histologically, acantholysis and dyskeratosis are the
two major hallmarks observed in lesional epidermis [1]. Interestingly,
both lesional and non-lesional DD keratinocytes appear to suffer ER Ca2þ
depletion and ER stress, but only lesional keratinocytes exhibit changes
in trafﬁcking and maturation of desmosomal proteins [9, 10], suggesting
the need for an interaction between secondary factors and the pathogenic
variant.
DD runs a chronic and relapsing course after its onset, which usually
occurs during the ﬁrst or second decade of life, and may aggravate with
age [3, 11]. Clinical manifestations include nail abnormalities and focal
skin lesions, characterized as redish-brownish crusted keratotic papules,eptember 2019
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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exacerbated by environmental factors, such as UV-B radiation, and are
more susceptible to infection by bacterial, fungal, and viral microor-
ganisms [3].
Additionally, a range of neuropsychiatric features such as depression,
suicidal behavior, bipolar disorder, schizophrenia, intellectual disability,
epilepsy, cognitive deﬁcit, mental retardation, and learning disability
have been reported in DD patients [12, 13, 14, 15]. Gordon-Smith et al.
have found higher lifetime prevalence rates of mood disorders (50%),
especially major depression (30%) and epilepsy (3%), to be present
within a sample of one hundred unrelated DD patients compared with
that in the general population [16].
Current treatments used to manage DD lack efﬁcacy and safety: oral
or systemic retinoids are the most frequently prescribed drugs, which
nevertheless harbor a large number of noxious side effects and cannot be
prescribed to women of child-bearing age [17].
In this study we aim to describe the molecular aspects, the clinical
features and the neuropsychiatric occurrences within this two-generation
Portuguese family carrying Darier disease.
2. Materials and methods
2.1. Participants
Five individuals from a two-generation Portuguese family carrying
Darier disease agreed to enroll in this study: four affected relatives and
one unaffected relative. This study was approved by the local Ethics
Committee, and written informed consents were obtained from each
participant in this study. The dermatologists who follow-up the patients
were informed about the study and gave their consent.
Data concerning the clinical manifestations and the neuropsychiatric
features of the affected individuals were gathered by medical note
assessment and interview.
2.2. PCR and RT-PCR ampliﬁcation
Nucleic acids were extracted from whole blood peripheral lympho-
cytes, collected from each individual. All exons and ﬂanking intronic
boundaries of genomic ATP2A2 were ampliﬁed by PCR using 17 sets of
primers designed with Primer3 program (http://primer3.ut.ee)
(Table 1). PCR conditions were the following: initial denaturation at 98
C for 30 s; 35 cycles of 98 C for 10 s; annealing at 55 C or 58 C for 10 s;Table 1
PCR and RT-PCR primers and related parameters for ampliﬁcation of genomic and co
Exon Forward Primer Rever
PCR ampliﬁcation 1 gcaagaggaggaggggaga ccatct
2 þ 3 cctccctcttgacacattgct agaca
4 catgttgggcaggttggtct ccattg
5 tgtccttgtgtctgttgcct tgaca
6 ctcatttcagccgccttt aaggg
7 ggtgggcatgaatgagaggt agtga
8 cagcgtcggtatttaagttggg acaaa
9 tgtttgcctttgtcctaagct tgccac
10 ggggcgggaggaatcaatag ctttca
11 gacagattgtgcttttgtgga gagag
12 þ 13 ttgccacccagtagtatcca tgcag
14 ggcaacaagagcgaaact gaggc
15 tttgccaagagacctacgg tttctg
16 ttttctggaggagggcg agggc
17 þ 18 ccggttaccatcactgtccc tgacta
19 þ 20 tactgccactgtgacacgtg gaaat
21 tctagatgctaccctgtgtgg tcagtc
RT-PCR ampliﬁcation 1–6 aagaggaggaggggagac ttcacc
6–8 tggtgacaaagttcctgctg tgcag
8–13 gctcttggaactcgcagaat acccc
13–15 acccacattcgagttggaag gccac
15–18 gtgaacgatgctcctgctct aaagt
17–20 ctgctgcatggtggttcat ttcagc
2extension at 72 C for 20 s; a ﬁnal extension step for 5 min. Each PCR
reaction was carried out in a total volume of 25 μL using the Phusion®
High-Fidelity DNA Polymerase (New England Biolabs) protocol, and
approximately 200 ng of genomic DNA. First strand cDNA was synthe-
sized from total RNA (1μg) usingMaxima First Strand cDNA Synthesis Kit
(Thermo Fisher Scientiﬁc). The entire coding region of SERCA2b cDNA
was ampliﬁed by PCR using six overlapping sets of primers, speciﬁcally
designed with Primer3 program (Table 1). Each PCR was performed
according to protocol for Phusion® High-Fidelity DNA Polymerase, with
annealing temperatures of 60 or 61 C, a ﬁnal MgCl2 concentration of 1.5
mM or 3.0 mM, in a total volume of 25 μL. RT-PCR products were run on
2% agarose gels for detection of splicing errors.
2.3. Sequence analysis
PCR and RT-PCR products were puriﬁed from solution or directly
from agarose gel, using Isolate II PCR and Gel Kit (Bioline). PCR forward
and/or reverse primers were added to the puriﬁed products from each
individual sample and submitted to bi-directional Sanger sequencing
(GATC Biotech). All chromatograms corresponding to PCR and RT-PCR
fragments were carefully analyzed using the BLAST program (NCBI).
2.4. Quantitative PCR
Quantitative PCR was performed using Maxima SYBR Green qPCR
Master Mix (Thermo Fisher Scientiﬁc) and the CFX96 Touch™ Real-Time
System (Bio-Rad). Two sets of primers were designed to amplify both
mutant and wild-type transcripts (GGTGACAAGTTCCTGCTGA forward
and AGTGTGCTTGATGACAGAGACA reverse), or the wild-type tran-
scripts only (TGTGCTCTTTGTAATGACTCTGC forward and AGAAA-
GACCCTTCAATTCGGTATCA reverse). The set of primers designed
strictly for wild-type transcripts allows the ampliﬁcation of exon 10,
which is missing in mutant mRNA, while the set of primers for both wild-
type and mutant anneals in exons 6 and 7. Target complementary DNA
sequences were normalized to beta-actin.
2.5. Western blotting
Whole blood peripheral lymphocytes were homogenized and proteins
were isolated using RIPA buffer (Pierce, Thermo Fisher Scientiﬁc), con-
taining protease and phosphatase inhibitors (Thermo Fisher Scientiﬁc).
An amount of 25 μg, evaluated by bicinchoninic acid method of totalding ATP2A2, respectively.
se Primer Product size (bp) Annealing Temperature (C)
tccctggctctccc 307 58
cagcttgcaactcca 354
cactccagcctg 480
ggaagggaggtgcta 490
acagtgaggcaagag 202
tggttggcagtgaaa 249
gaaccacgacacgga 573
accagatcctttaaa 225
ttccacccacccca 234
taggacagtgcagaca 309
ggtgtggacaaagaa 516
tactatgtgcttgtg 478
tcttgcccactccc 483 55
atctctgtcttttgc 426
cacacaattccccgg 690
cccatcggtgcatgc 449 58
atgcacagggttgg 299
tgtgagaattgactgg 676 61
actgacatctggtttg 629 60
actctcgaatgacag 699
aatggtggagaagtt 659
ccgggttgtcctctt 537
agaaatagacagttgctt 663
Fig. 1. Pedigree of the two-generation Portuguese family where Darier Disease
segregates. The affected individuals are denoted by solid black symbols whereas
unaffected individuals are denoted by open symbols. Arrows point to the in-
dividuals who participated in this study.
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sets of samples were studied as heated (95 C for 5 min) and unheated
samples, which were resolved in 7.5% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto
polyvinylidene diﬂuoride membranes (GE Healthcare Life Sciences,
Amersham Hybond) at 300 mA for 100 min at 4 C. Blots were blocked
with a solution containing 5% bovine serum albumin, TBS (1x), and 0.1%
Tween® 20 for 1 h at room temperature, followed by incubation with
rabbit polyclonal anti-SERCA2 (dilution 1:10000; #4388 Cell Signaling).
Membranes were probed with anti-rabbit IgG secondary antibody (dilu-
tion 1:2000; #7074, Cell Signaling Technologies, Inc.), followed
chemiluminescent detection with SuperSignal West Femto Maximum
Sensitivity Substrate (Thermo Fisher Scientiﬁc). SERCA2 expression was
normalized to beta-actin (dilution 1:4000; Sigma-Aldrich).
2.6. Genotype-phenotype correlation
Sequenced exons and ﬂanking intronic boundaries from ATP2A2
were analyzed closely in search for genetic variants other than the
pathogenic mutation. Additionally, ATP2A2 and SERCA2 expression
levels were also considered for genotype-phenotype correlation.
3. Results
3.1. Clinical characterization of the DD patients
The pedigree structure of the two-generation family under study is
depicted in Fig. 1. All affected family members were diagnosed by der-
mopathology during their ﬁrst decade of life. These individuals shared a
monomorphic dermatosis, notably symmetrical, containing multiple
non-follicular hyperkeratotic papules with 2–4 mm in diameter,
brownish, rounded and occasionally crusted, on skin usually healthy or
erythematous skin during periods of inﬂammatory exacerbation. The
lesions were distributed along the entire lateral cervical region, anterior
thorax and lower abdominal region (especially ﬂanks), appearing also in
the scalp, and predominant in retroauricular region. Palms of the hands
presentedmultiple millimetric depressions ﬁlled by keratin (palmar pits).
Nails of the hands and feet presented discrete longitudinal leukonychia,
fragility, ﬁssure and dyskeratosis with V-shaped notches on the distal end
of the nail plate. Relapses of greater clinical severity usually led to skin
eruptions or infections by bacterial agents. Patients’ clinical course was
in line with the worsening of the disease over the years. Moreover, pa-
tients agreed that skin lesions were exacerbated by sweat, friction, and
sunlight, particularly during the summer.
However, the clinical severity of the disease varied from patient to
patient. At the skin level, patient I.2 had more relapses than his brother
(I.3) whereas patient II.1's relapses were more frequent and more severe
than those of his father (I.2). In addition to their skin phenotype, viral,
immunologic, and neuropsychiatric occurrences weremainly observed in
the younger patients (II.1 and II.3) (Table 2).
To manage DD, the patients took medicines prescribed by dermatol-
ogists such emollients, topical antibiotics, and retinoids such as acitretin,
a derivative of vitamin A. They also avoided being exposed to the sun
during the summer in order to prevent focal lesions to emerge or exac-
erbate. Patients with other occurrences, referred in Table 2, took addi-
tional medicines to manage these.
3.2. Splice-site mutation in ATP2A2 gene leads to exon skipping followed
by frameshift and premature nonsense codon
In order to identify the pathogenic variant, we analyzed the genomic
and messenger sequences of ATP2A2 gene. Bi-directional Sanger
sequence analysis of all exons and respective intronic boundaries
revealed a substitution in the canonical splice donor site of the guanine
(þ1) for a thymine in intron 10 (c.1287þ1G > T or IVS10þ1G > T)
(Fig. 2); no additional sequence alterations were detected in any3individual. Disruption of the mutant pre-mRNA splicing process was
proposed by several public bioinformatic programs, namely Human
Splicing Finder (http://www.umd.be/HSF3/) and NetGene2
(http://www.cbs.dtu.dk/services/NetGene2).
By analyzing RT-PCR products spanning exons 8 to 13 from ATP2A2
gene, we conﬁrmed that the splicing process is affected, leading to a
shorter transcript (596 bp) in each affected relative (I.2, I.3, II.1 and II.3),
whereas the unaffected relative (II.2) showed a normal RT-PCR fragment
(699 bp) equivalent to two copies of the wild-type ATP2A2 gene (Fig. 3a).
Bi-directional sequence analysis of these RT-PCR products, whose normal
and shorter fragments were directly puriﬁed from the gel, revealed the
skipping of full exon 10 in the shorter transcript of each affected relative
(Fig. 3b), whereas the normal fragment corresponded to the sequence
derived from the wild-type ATP2A2. Therefore, all four patients were
shown to carry the same mutation in heterozygosity, which, leading to
the skipping of exon 10, consequently originates a frameshift, which
putatively introduces a downstream premature stop codon (p.V395 ¼
fs*19) in exon 11.
Furthermore, it was proved that the unaffected individual carries two
normal alleles, what allowed us to use her as a control in subsequent
analyses since she shares the same genetic background of all the patients.
3.3. Wild-type SERCA2 mRNA expression is signiﬁcantly decreased while
mutant mRNA appears to partially escape Nonsense-Mediated mRNA
Decay (NMD)
We decided to examine the expression levels of both wild-type and
mutant SERCA2mRNA by quantitative PCR. Results revealed a reduction
of approximately 50–55% of wild-type plus mutant SERCA2 mRNA
expression when compared to the healthy subject, whose expression was
considered 100% (Fig. 4a). Relative expression levels of wild-type mRNA
alone corresponded to approximately 36% in the patients, whereas the
mutant mRNA expression corresponded to 18% (Fig. 4b). These ﬁndings
were in agreement with what is seen in Fig. 3a, highly suggesting that a
small amount of mutant SERCA2 mRNA fails to be recognized by NMD,
which could potentially lead to the generation of abnormal SERCA2
protein.
3.4. Wild-type SERCA2 is signiﬁcantly reduced whereas mutant SERCA2
is not detected
If translated, the mutant SERCA2mRNAwould originate an abnormal
Table 2
Additional information about participants’ actual age, age of onset, and other phenotypic manifestations.
Individuals Actual Age Age of DD onset Cutaneous phenotype Neuropsychiatric co-occurrences Other occurrences
I.2 56 1st decade of life, around six years old þþ None Herpes simplex virus in the left eye
I.3 61 þ None None
II.1 31 þþþ Single suicide attempt
Depressive moods
Membranous glomerulonephritis
Left ear deafness
Chronic left middle ear infection
II.3 34 þ Epilepsy Leukemia
II.2 24 - - None None
Fig. 2. Identiﬁcation of ATPase sarcoplasmic/endoplasmic reticulum Ca2þ transporting 2 (ATP2A2) pathogenic mutation. Sanger sequencing of the ATP2A2 gene
revealed the transversion c.1287þ1G > T or IVS10þ1G > T in intron 10.
Fig. 3. The IVS10þ1G > T variant leads to full skipping of exon 10. (a) Agarose gel electrophoresis of RT-PCR products, spanning exons 8 to 13, revealed the presence
of two bands in the patients, the bigger one corresponding to the wild-type transcript and the shorter one to the mutant transcript, whereas the unaffected member
revealed a single band corresponding to the wild-type transcripts. M- Molecular marker (pBR322 x MspI, New England Biolabs). (b) Sequence analysis of the shorter
DNA fragment, puriﬁed directly from the gel, revealed the skipping of the entire region of exon 10 in every affected relative.
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acids rather than the expected 1042 (SERCA2b). The amino acid
sequence would be normal until Val395; it would lack the residues
encoded by exon 10, which form part of the phosphorylation domain;
and the sequence encoded by exon 11, from residue 396 to 413, would be
completely abnormal. All mutant SERCA2 splicing variants would lose
highly conserved amino acids and motifs hence it would no longer have
most of phosphorylation domain, and completely lack the nucleotide-
binding and hinge domains, the ﬁfth stalk domain, the transmembrane
domains 5 to 10, or 11 in case of SERCA2b.
Therefore, when assessing expression levels of SERCA2, it might be
expected to observe a band around 115 kDa, corresponding to the4wild-type pump, and another band of 45 kDa, corresponding to the
mutant pump. Nevertheless, western blot results showed no signal of
mutant protein in the affected relatives, whereas wild-type SERCA2
presented signiﬁcantly reduced expression levels, between 40 and
50%, when compared to the healthy individual (Figs. 5a and 5b). Our
results showed that the mutant SERCA2 mRNA escaping to NMD is not
translated or, if translated, is very unstable and immediately
degraded.
3.5. Proposed pathogenic mechanism
Besides gain of function mutations, autosomal dominant disorders
Fig. 4. All patients showed Sarco/Endoplasmic Reticulum Ca2þ ATPase 2 (SERCA2) mRNA levels lower than 50% and residual levels of mutant mRNA. Quantitative
PCR analysis was performed to quantify the expression levels of (a) both wild-type and mutant transcripts and (b) wild-type transcripts alone. The data are presented as
the mean  SD of three independent experiments.
Fig. 5. SERCA2 expression was increasingly reduced in patients when compared with the unaffected relative and the presence of the putative truncated protein was
not detected in Darier Disease patients. (a) Wild-type SERCA2 was signiﬁcantly reduced in affected individuals. Lymphocytes were lysed with 0.1% SDS and the
resulting supernatants were resolved by 7.5% SDS-PAGE loaded with reduced, unheated samples. Anti-SERCA2 antibody was used for the western blots. After being
washed, the same membrane was blotted with anti-beta-actin as the loading control. (b) Putative mutant SERCA2 (45 kDa) could not be detected by western blot. Blots
were incubated with anti-SERCA2 antibody only in order to detect the putative mutant SERCA2. The marker used was NZYColour Protein Marker II (Nzytech). Note:
no endogenous control was used because the objective was to detect the putative presence of the mutant SERCA2 protein.
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haploinsufﬁciency or dominant-negative effects. In this speciﬁc family
where Darier disease segregates, and which is caused by the loss of
function c.1287þ1G > T or IVS10þ1G > T mutation, we could observe
that no abnormal variant protein was produced (Fig. 5b); accordingly, a
dominant-negative effect may be excluded. So, haploinsufﬁciency ap-
pears to be the most plausible pathogenic mechanism causing this disease
condition.
3.6. No genotype-phenotype correlation was found
Since all patients revealed similar levels of SERCA2 expression, we
expected to ﬁnd additional mutation(s) in the ATP2A2 gene, whichmight
explain or contribute to the variable phenotypic spectra displayed by the
four DD patients. Nevertheless, after screening by Sanger sequencing all
exons and respective boundaries, no additional polymorphisms were
identiﬁed.
4. Discussion
One pivotal point in this study was the identiﬁcation of the disease-5causing mutation in these family. The c.1287þ1G > T or IVS10þ1G >
T transversion fulﬁls several criteria for being considered a pathogenic
variant, namely: it is located at canonicalþ1 splice site originating a null
variant in the ATP2A2 gene where loss of function is a knownmechanism
of disease [18, 19]; it had been previously identiﬁed in a Japanese female
patient presenting the same phenotype of Darier disease [20].
Another point was to elucidate how c.1287þ1G > T affects splicing
and the pathogenic mechanism. This transversion immediately reduces
the stability of base pairing of the 5'splice site with the complementary
region of U1 snRNA [21] and subsequent consequences demonstrate how
crucial the highly conserved splice donor site is to the splicing process.
The reason why c.1287þ1G > T led to exon skipping rather than cryptic
splice site usage may rely on potential spliceosome's functional response
inﬂuencing factors, such as local sequence context of the affected
exon-intron junction and vicinities [22]; RNA secondary structure [22];
or open reading frame conservation [22]. The mutant mRNA contains a
putative PTC located 74 bp upstream the 30-most exon-exon junction
(exon11-exon12). According to the 50–55 bp rule, a transcript containing
a PTC located upstream 50–55 bp from the 30-most exon-exon junction is
immediately recognized by the NMD system [23]. However, herein, the
mutant SERCA2 mRNA is not entirely degraded but the putative
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SERCA2 is too unstable and immediately degraded by proteasomes, or
that the translation of mutant mRNA is repressed by another surveillance
mechanism [23]. Studies point that translational repression might
depend on a putative cis-element residing in 30-UTR, such as DNA
transposons [23, 24]. Shen et al. revealed that miniature inverted-repeat
transposable elements in the 30-UTRs function as important regulators of
translation, therefore these could be potential cis-element candidates
[24]. Because putative mutant SERCA2 was not detected in the affected
relatives, dominant-negative effect by SERCA2 oligomerization is un-
likely to occur. Rather, although heterozygous ATP2A2 knockout mice do
not exhibit DD features [8, 25, 26], this study demonstrates that, in these
patients, the identiﬁed splice-site mutation in ATP2A2 appears to pro-
duce a dominant DD phenotype through haploinsufﬁciency.
The previous results, when compared with the main dermatological
features of patients, strongly suggest that one single normal ATP2A2
allele is not enough to maintain Ca2þ homeostasis in the skin, the organ
mostly exposed to outside inﬂuence and where SERCA2b is expressed at
higher levels.
Because all patients demonstrate similar levels of ATP2A2mRNA and
protein expression, haploinsufﬁciency of SERCA2 by itself cannot explain
the variable clinical severity observed among affected relatives. Never-
theless, the phenotype of heterozygous individuals becomes more prone
to external inﬂuences, as it usually occurs in dominant inherited disor-
ders [18]. Herein, we wanted to examine genotype-phenotype relation-
ships by screening all exons and intronic ﬂanking regions of ATP2A2
gene for additional variants and try to correlate these with the patients'
clinical history and different clinical severity. However, no additional
polymorphisms were found. Nevertheless, ATP2A2 contains several in-
trons with extensive size that were not entirely sequenced. Thus, we
cannot demonstrate whether additional deep-intronic variants or large
insertions/deletions exist within these regions.
Although no genotype-phenotype relationship has been found, we
highlight that, not only genetic factors play an important role in
phenotypic variability, but also non-genetic factors. SERCA2 pleiotropy,
impairment in a SERCA2 epistatic partner, epigenetic changes, or
different lifestyles, could play a role in phenotypic variability.
In this two-generation family, some patients have developed non-
cutaneous phenotypes that we ﬁnd relevant to report. Depressive
moods and epilepsy have been reported in patient II.1 and patient II.3,
respectively. Disruption of intracellular Ca2þ homeostasis and function of
adhesion molecules has been reported in both abovementioned neuro-
psychiatric conditions, epilepsy and depressive moods; moreover, it has
already been described that the prevalence rates of these conditions are
higher in DD patients than in general population [4, 17]. Because the
other affected relatives do not show these symptoms, it seems that these
may not be a direct consequence of the ATP2A2 mutation alone. Rather,
these phenotypes might need to occur in the presence of environmental
factors and genetic variants other than the ATP2A2mutation, either from
the same or different loci.
Renal complications have also been reported in DD patients [27, 28].
Herein we report a case of membranous nephropathy from patient II.1.
We cannot conclude whether this disease occurs by chance or the
opposite. It is well established, however, that ER stress is one of the major
causes of kidney disease [29].
Additionally, a number of ocular features have been previously
described in DD patients [30, 31, 32, 33]. We report a case of herpes virus
simplex (HSV) infection in the cornea of the left eye of patient I.2 and
alert for the relationship between possible impaired adhesion molecules
in the corneal epithelium and the increased risk of HSV infection. Patient
I.2 has been submitted to two transplants of the affected cornea.
Lastly, we report in patient II.1a case of chronic middle ear infection
due to recurrent skin lesions in the ear, which have damaged the eardrum
and reduced hearing capacity of the left ear.6In conclusion, this study identiﬁed the disease-causing mutation in
this family and contributed to enlarge the worldwide mutational spec-
trum of DD. This study also conﬁrmed the phenotypic variability of this
pathology, namely reporting the presence of neuropsychiatric symptoms,
thus highlighting the importance of a wide range of clinical occurrences
deserving to be closely monitored.
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